Peptide AOD 9604 benefits center on fat metabolism, not muscle growth. Learn what studies show, typical dosing, forms, and safety limits in humans.
AOD 9604 is a synthetic fragment of human growth hormone that researchers have studied for its ability to increase fat breakdown without raising blood sugar or triggering growth effects. Most of the evidence comes from animal studies and a small number of early human trials, and the peptide is not FDA-approved for human use. The peptide AOD 9604 benefits discussed most often are fat loss, improved fat metabolism, and possible cartilage support.
What AOD 9604 Is
AOD 9604 is a shortened piece of the human growth hormone molecule. It contains the C-terminal region of hGH (roughly amino acids 177-191) plus a tyrosine added to the front of the chain, which helps the fragment survive digestion and metabolic breakdown.
Researchers in Australia developed it in the 1990s to separate hGH's fat-burning effects from everything else growth hormone does. The goal was a compound that could drive lipolysis, the breakdown of stored fat, without raising IGF-1, disrupting blood glucose, or promoting tissue growth.
That distinction matters. AOD 9604 does not behave like full growth hormone, and it is not the same thing as hGH or any growth-hormone-releasing peptide.
How AOD 9604 Works in the Body
The fragment mimics one narrow slice of hGH activity: it appears to stimulate fat cells to release stored triglycerides and to reduce the formation of new fat. In laboratory and animal studies, this happened without the blood sugar spikes associated with some other metabolic compounds.
Human data is much thinner. A Phase IIb trial in obese adults produced only modest average weight loss, and development was discontinued after results fell short of the company's targets. That outcome is the main reason AOD 9604 remains a research compound rather than a prescription drug.
Some early work also explored the fragment's effects on cartilage and connective tissue repair, but that research is preliminary and has not produced confirmed human benefits.
Reported Benefits and the Evidence Behind Them
Online discussion of the benefits of aod 9604 peptide often runs ahead of the science. The table below separates the claims people make from what published research actually supports.
| Claimed benefit | What the research shows | Strength of evidence |
|---|---|---|
| Fat loss | Human trials showed small average weight reduction; at least one trial missed its primary endpoint | Low to moderate |
| Fat breakdown without blood sugar rise | Short-term studies did not show meaningful glucose or insulin disruption | Moderate, short-term only |
| Preservation of lean muscle | Not demonstrated in controlled human trials | Weak |
| Improved cholesterol or lipid profile | Limited and inconsistent data | Weak |
| Joint and cartilage support | Early lab and animal findings only | Very weak |
Two points are worth stating plainly. AOD 9604 has not been proven to cause significant weight loss in humans. No published trial has shown that AOD 9604 builds muscle or preserves lean mass.
Forms, Dosing, and Timing
AOD 9604 is sold in several delivery formats, and they are not equivalent. Injectable vials are the form used in clinical research, while other formats are marketed with far less supporting data.
| Form | Typical presentation | Practical notes |
|---|---|---|
| Subcutaneous injection | Lyophilized powder, commonly sold in 10 mg vials and reconstituted with bacteriostatic water | The only form studied in human trials; requires sterile technique |
| Oral capsules | aod 9604 peptide capsules sold as supplements | Peptides are generally broken down in the stomach, so oral absorption is questionable |
| Nasal spray | aod 9604 peptide nasal spray in liquid bottles | Absorption through nasal tissue is unproven for this molecule |
There is no FDA-approved dosing standard for AOD 9604. Trials used roughly 1 mg per day by injection, while online protocols often describe much smaller amounts, and no starting protocol has been validated by research.
Timing advice is likewise unsupported. People asking when to take aod 9604 peptide are usually told to inject in a fasted state or before exercise, but no trial has compared timing strategies head to head.
Anyone looking to buy aod-9604 peptide should expect to find it sold as a research chemical rather than a supplement or medication. Third-party purity testing and a certificate of analysis matter more than label claims, because research peptides are not held to pharmaceutical manufacturing standards.
Safety, Legality, and Side Effects
AOD 9604 is not FDA-approved for human use in the United States. It is not a lawful ingredient in dietary supplements, and products sold as AOD 9604 supplements sit in a gray area that leaves buyers outside any regulatory safety net.
In clinical trials, reported side effects were generally mild and included headache, nausea, and injection-site reactions. Long-term safety data does not exist, and effects on pregnancy, thyroid function, and hormone signaling have not been properly studied.
The World Anti-Doping Agency prohibits AOD 9604 for athletes both in and out of competition. Anyone subject to drug testing should treat it as a banned substance.
Most AOD 9604 marketing describes effects that controlled human trials have not confirmed.
Bottom Line
- AOD 9604 is a growth hormone fragment studied for fat metabolism, not a proven weight-loss drug.
- Human trials produced only modest results, and development was discontinued.
- Injectable AOD 9604 is the only form with human data; capsules and nasal sprays lack evidence.
- AOD 9604 is not FDA-approved for human use and is banned by WADA.
- Claims about muscle gain, joint repair, or dramatic fat loss are not supported by controlled human research.
Frequently Asked Questions
Is AOD 9604 FDA approved?
No. AOD 9604 is not FDA-approved for human use in the United States, and it is not a permitted ingredient in dietary supplements. It is sold as a research chemical, which means it has not been reviewed for safety, purity, or effectiveness by any regulator.
Does AOD 9604 actually burn fat?
Human trials showed only small average weight loss, and at least one study failed to meet its primary endpoint. Laboratory and animal research suggests the fragment can stimulate fat breakdown, but that effect has not translated into meaningful, proven fat loss in people.
What is a typical AOD 9604 dosage?
There is no established or FDA-approved dose for AOD 9604. Clinical trials used roughly 1 mg per day by injection, but no safe or effective human dose has been confirmed, and self-dosing with research-grade peptides carries unknown risks.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.